 |
5a8, monoclonal antibody to CD4 |
|---|---|
| Trade Name | |
| Orphan Indication | For use in post-exposure prophylaxis for occupational exposure to human immunodeficiency virus |
| USA Market Approval | USA |
| USA Designation Date | 1993-12-20 00:00:00 |
| Sponsor | Biogen, Inc.;14 Cambridge Center;Cambridge, Massachusetts, 02142 |
